Unknown OBSERVATIONAL NCT03591315

Clinical Study of Structural and Functional Evaluation of the Visual Pathway

Multimodal Evaluation on Visual Pathway Predicts the Surgical Curative Effects in Sellar Area Tumors

Sponsor: Xiangya Hospital of Central South University

Conditions Neuroimaging Pituitary Adenoma Sellar Tumor Visual Impairment

Interventions automated visual field diffusion tensor imaging resting state fMRI visual acuity visual tasking state fMRI

Updated 5 times since 2018 Last updated: Jul 19, 2018 Started: Jul 31, 2018 Primary completion: Dec 31, 2018 Completion: Jan 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Neuroimaging and Pituitary Adenoma and is currently ongoing. Xiangya Hospital of Central South University leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jul 2020 — Jan 2021 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Aug 2018 — Jul 2020 [monthly]

Not Yet Recruiting

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xiangya Hospital of Central South University

Data source: Xiangya Hospital of Central South University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Changsha, China